CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade?

Carbohydrate antigen 19-9, also known as Cancer Antigen (CA 19-9) is a tumour marker found elevated in certain ovarian tumours. Although, reports of its association with mature teratoma are considerable, little is mentioned about its association with immature teratoma. This could be attributed to im...

Full description

Bibliographic Details
Main Authors: Julie H John, R Sanghamita, Ajay Halder, Sramana Mukhopadhyay, Shweta Patel
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2022-06-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/16543/53781_CE_[Nik]_F(KR)_PF1(SC_SS)_PFA(SC_KM)_PN(KM).pdf
_version_ 1797924647298138112
author Julie H John
R Sanghamita
Ajay Halder
Sramana Mukhopadhyay
Shweta Patel
author_facet Julie H John
R Sanghamita
Ajay Halder
Sramana Mukhopadhyay
Shweta Patel
author_sort Julie H John
collection DOAJ
description Carbohydrate antigen 19-9, also known as Cancer Antigen (CA 19-9) is a tumour marker found elevated in certain ovarian tumours. Although, reports of its association with mature teratoma are considerable, little is mentioned about its association with immature teratoma. This could be attributed to immature teratoma being a rare tumour with only a few studies on its tumour markers. Authors present the case of a 24-year-old female presenting with ovarian immature teratoma who also showed unusually high serum levels of CA 19-9 which reduced drastically after surgery. This association therefore may warrant further investigations to establish the clinical relevance and its importance in future.
first_indexed 2024-04-10T15:05:22Z
format Article
id doaj.art-7037f1d745a148d59433cbe3d90e5418
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-10T15:05:22Z
publishDate 2022-06-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-7037f1d745a148d59433cbe3d90e54182023-02-15T05:17:25ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2022-06-01166QD01QD0210.7860/JCDR/2022/53781.16543CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade?Julie H John0R Sanghamita1Ajay Halder2Sramana Mukhopadhyay3Shweta Patel4Junior Resident, Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.Junior Resident, Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.Associate Professor, Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.Associate Professor, Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.Assistant Professor, Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.Carbohydrate antigen 19-9, also known as Cancer Antigen (CA 19-9) is a tumour marker found elevated in certain ovarian tumours. Although, reports of its association with mature teratoma are considerable, little is mentioned about its association with immature teratoma. This could be attributed to immature teratoma being a rare tumour with only a few studies on its tumour markers. Authors present the case of a 24-year-old female presenting with ovarian immature teratoma who also showed unusually high serum levels of CA 19-9 which reduced drastically after surgery. This association therefore may warrant further investigations to establish the clinical relevance and its importance in future.https://www.jcdr.net/articles/PDF/16543/53781_CE_[Nik]_F(KR)_PF1(SC_SS)_PFA(SC_KM)_PN(KM).pdfabdominopelvic massadjuvant chemotherapycarbohydrate antigen 19-9multiloculated solid-cystic lesion
spellingShingle Julie H John
R Sanghamita
Ajay Halder
Sramana Mukhopadhyay
Shweta Patel
CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade?
Journal of Clinical and Diagnostic Research
abdominopelvic mass
adjuvant chemotherapy
carbohydrate antigen 19-9
multiloculated solid-cystic lesion
title CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade?
title_full CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade?
title_fullStr CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade?
title_full_unstemmed CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade?
title_short CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade?
title_sort ca 19 9 in ovarian immature teratoma a potential tumour marker or a masquerade
topic abdominopelvic mass
adjuvant chemotherapy
carbohydrate antigen 19-9
multiloculated solid-cystic lesion
url https://www.jcdr.net/articles/PDF/16543/53781_CE_[Nik]_F(KR)_PF1(SC_SS)_PFA(SC_KM)_PN(KM).pdf
work_keys_str_mv AT juliehjohn ca199inovarianimmatureteratomaapotentialtumourmarkeroramasquerade
AT rsanghamita ca199inovarianimmatureteratomaapotentialtumourmarkeroramasquerade
AT ajayhalder ca199inovarianimmatureteratomaapotentialtumourmarkeroramasquerade
AT sramanamukhopadhyay ca199inovarianimmatureteratomaapotentialtumourmarkeroramasquerade
AT shwetapatel ca199inovarianimmatureteratomaapotentialtumourmarkeroramasquerade